E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 387.25 INR 1.05%
Market Cap: 262.3B INR
Have any thoughts about
Emcure Pharmaceuticals Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Emcure Pharmaceuticals Ltd

Current Assets 42.6B
Cash & Short-Term Investments 5.2B
Receivables 21.1B
Other Current Assets 16.3B
Non-Current Assets 35.5B
Long-Term Investments 199.9m
PP&E 24B
Intangibles 8.9B
Other Non-Current Assets 2.4B
Current Liabilities 32.1B
Accounts Payable 13.1B
Accrued Liabilities 1.9B
Short-Term Debt 9.6B
Other Current Liabilities 7.5B
Non-Current Liabilities 16.4B
Long-Term Debt 9.8B
Other Non-Current Liabilities 6.6B

Balance Sheet
Emcure Pharmaceuticals Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
1 628
2 423
1 690
Cash
1 628
2 423
1 084
Cash Equivalents
1
1
606
Short-Term Investments
1 455
2 045
3 484
Total Receivables
15 157
19 024
21 133
Accounts Receivables
13 134
16 597
18 735
Other Receivables
2 023
2 427
2 399
Inventory
14 494
13 830
15 251
Other Current Assets
1 506
1 036
1 041
Total Current Assets
34 241
38 359
42 599
PP&E Net
19 855
22 148
23 972
PP&E Gross
19 855
22 148
23 972
Accumulated Depreciation
9 316
11 047
13 076
Intangible Assets
1 614
1 258
5 078
Goodwill
2 174
2 177
3 787
Note Receivable
852
834
1 045
Long-Term Investments
461
581
200
Other Long-Term Assets
1 438
1 368
1 381
Other Assets
2 174
2 177
3 787
Total Assets
60 635
N/A
66 725
+10%
78 062
+17%
Liabilities
Accounts Payable
11 252
10 861
13 094
Accrued Liabilities
1 558
1 737
1 931
Short-Term Debt
10 910
11 453
9 620
Current Portion of Long-Term Debt
2 977
3 297
3 907
Other Current Liabilities
2 952
2 844
3 554
Total Current Liabilities
29 648
30 192
32 105
Long-Term Debt
8 286
8 593
9 823
Deferred Income Tax
426
389
1 374
Minority Interest
1 266
1 485
1 695
Other Liabilities
1 133
1 055
3 542
Total Liabilities
40 759
N/A
41 714
+2%
48 539
+16%
Equity
Common Stock
1 809
1 809
1 812
Retained Earnings
17 910
22 938
27 125
Additional Paid In Capital
0
0
99
Other Equity
157
265
487
Total Equity
19 875
N/A
25 011
+26%
29 523
+18%
Total Liabilities & Equity
60 635
N/A
66 725
+10%
78 062
+17%
Shares Outstanding
Common Shares Outstanding
189
189
189

See Also

Discover More